Factors associated with persistent post-Covid-19 symptoms in adult patients
Keywords:
Factores de riesgo; Covid-19; Síndrome post agudo de Covid-19; Pacientes; Adulto; Signos y síntomasAbstract
Introduction: Patients who have suffered from Covid-19 disease tend to recover, but there is a proportion who continue to present persistent symptoms; therefore, it is important to identify their associated factors.
Objective: Determine the factors associated with persistent post-Covid-19 symptoms in adult patients treated at the Ate Vitarte Emergency Hospital, 2021.
Methods: Observational, non-experimental, quantitative, case-control and retrospective study. The sample was 214 adult patients, of which 107 were from the case group and 107 from the control group; The sampling was systematic probabilistic. Statistical analyzes were performed using the Chi square test and binary logistic regression. Approval was obtained from the hospital ethics committee.
Results: According to the bivariate analysis, age from 36 to 65 years (p=0,000; OR=3,518), presenting at least one comorbidity (p=0,002; OR=2,596), having vaccines against Covid-19 (p=0,001; OR=14,660), obese (p=0,023; OR=1,920), presenting severe initial Covid-19 (p=0,000; OR=4,062), oxygen therapy (p=0,002; OR=2,765) and admission to the ICU (p =0,005; OR=2,360) were significantly associated with persistent post-Covid-19 symptoms. However, the multivariate analysis finally demonstrated that age from 36 to 65 years (p=0,004; ORa=4,918) and the presence of at least one comorbidity (p=0,010; ORa=2,738) were factors significantly associated with persistent symptoms post-Covid-19.
Conclusions: There are factors significantly associated with persistent post-Covid-19 symptoms; stories like the age of 36 to 65 years and having comorbidities.
Downloads
References
1. Pan American Health Organization. La OMS caracteriza a COVID-19 como una pandemia [Internet]. Washington, D.C.: PAHO; 2020 [consultado 24/02/2026]. Disponible en: https://www.paho.org/es/noticias/11-3-2020-oms-caracteriza-covid-19-como-pandemia
2. Wang C, Wang Z, Wang G, Lau JY, Zhang K, Li W. COVID-19 in early 2021: current status and looking forward. Signal Transduct Target Ther [Internet]. 2021 [citado 24/02/2026]; 6(1):114. Disponible en: https://doi.org/10.1038/s41392-021-00527-1
3. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol [Internet]. 2020 [citado 24/02/2026]; 215:108427. Disponible en: https://doi.org/10.1016/j.clim.2020.108427
4. Peralta G, Carozzo T, Sierra M, Bu E. Enfermedad por coronavirus (COVID-19): la pandemia según la evidencia actual. INNOVARE [Internet]. 2020 [citado 24/02/2026]; (1): 15-27. Disponible en: https://revistas.unitec.edu/innovare/article/view/108
5. Cieza Zevallos J, Uriol Lescano C. Letalidad y la mortalidad de Covid 19 en 60 países afectados y su impacto en los aspectos demográficos, económicos y de salud. Rev Méd Hered [Internet]. 2021 [citado 24/02/2026]; 31(4):214-21. Disponible en: https://revistas.upch.edu.pe/index.php/RMH/article/view/3852
6. Díaz-Castrillón FJ, Toro-Montoya AI. SARS-CoV-2/COVID-19: el virus, la enfermedad y la pandemia. Medicina & Laboratorio [Internet]. 2020 [citado 24/02/2026]; 24(3): 183-205. Dipsonible en: https://www.medigraphic.com/pdfs/medlab/myl-2020/myl203b.pdf
7. Donders F, Lonnée-Hoffmann R, Tsiakalos A, Mendling W, Martinez de Oliveira J, Judlin P, et al. ISIDOG Recommendations Concerning COVID-19 and Pregnancy. Diagnostics (Basel) [Internet]. 2020 [citado 24/02/2026]; 10(4):243. Disponible en: https://doi.org/10.3390/diagnostics10040243
8. World Health Organization. Afección pos-COVID-19 (COVID-19 prolongada) [Internet]. Geneva: WHO; 2025 [consultado 24/02/2026]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/post-covid-19-condition-(long-covid)
9. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol [Internet]. 2023 [citado 24/02/2026]; 21(3):133-146. Disponible en: https://doi.org/10.1038/s41579-022-00846-2
10. Al-Aly Z, Davis H, McCorkell L, Soares L, Wulf-Hanson S, Iwasaki A, Topol EJ. Long COVID science, research and policy. Nat Med [Internet]. 2024 [citado 24/02/2026]; 30(8):2148-2164. Disponible en: https://doi.org/10.1038/s41591-024-03173-6
11. Fumagalli C, Zocchi C, Tassetti L, Silverii MV, Amato C, Livi L, et al. Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study. Eur J Intern Med [Internet]. 2022 [citado 24/02/2026]; 97:36-41. Disponible en: https://doi.org/10.1016/j.ejim.2021.11.018
12. Chopra V, Flanders SA, O'Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med [Internet]. 2021 [citado 24/02/2026]; 174(4):576-578. Disponible en: https://doi.org/10.7326/m20-5661
13. Mauricio Trelles PB, Gutierrez Cadillo DN. Caracterización clínica epidemiológica de las secuelas Covid-19 en adultos recuperados de un hospital de Huancayo. Rev Peru Cienc Salud [Internet]. 2022 [citado 24/02/2026]; 4(1): 9-15. Disponible en: http://revistas.udh.edu.pe/RPCS/article/view/364e
14. World Health Organization. Global COVID-19 Clinical Platform Case Report Form (CRF) for Post COVID condition (Post COVID-19 CRF) [Internet]. Geneva: WHO; 2021 [consultado 24/02/2026]. Disponible en: https://www.who.int/publications/i/item/global-covid-19-clinical-platform-case-report-form-(crf)-for-post-covid-conditions-(post-covid-19-crf-)
15. Unidad de Análisis y Generación de evidencias en Salud Pública. Nota Técnica COVID-19 N°022-2022: Prevalencia, manifestaciones clínicas y factores asociados al desarrollo de COVID-19 de larga duración [Internet]. Lima: Instituto Nacional de Salud; 2022 [consultado 24/02/2026]. Disponible en: https://docs.bvsalud.org/biblioref/2022/05/1369443/nt_22_longcovid.pdf
16. de la Calle Castro A, Tello Carhuanca R, Villegas Felix T, Suasnabar E. Factores de comorbilidad y secuelas de COVID-19 en trabajadores de un Hospital Nacional de Huancayo 2021. Visionarios en ciencia y tecnología [Internet]. 2021 [citado 24/02/2026]; 6(1): 111-121. Disponible en: https://doi.org/10.47186/visct.v6i2.97
17. Hossain MA, Hossain KMA, Saunders K, Uddin Z, Walton LM, Raigangar V, et al. Prevalence of Long COVID symptoms in Bangladesh: a prospective Inception Cohort Study of COVID-19 survivors. BMJ Glob Health [Internet]. 2021 [citado 24/02/2026]; 6(12): e006838. Disponible en: https://doi.org/10.1136/bmjgh-2021-006838
18. Leung JM, Niikura M, Yang CWT, Sin DD. COVID-19 and COPD. Eur Respir J [Internet]. 2020 [citado 24/02/2026]; 56(2):2002108. Disponible en: https://doi.org/10.1183/13993003.02108-2020
19. Boglione L, Meli G, Poletti F, Rostagno R, Moglia R, Cantone M, et al. Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect? QJM [Internet]. 2022 [citado 24/02/2026]; 114(12):865-871. Disponible en: https://doi.org/10.1093/qjmed/hcab297
20. Iqbal A, Iqbal K, Arshad Ali S, Azim D, Farid E, Baig MD, et al. The COVID-19 Sequelae: A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors. Cureus [Internet]. 2021 [citado 24/02/2026]; 13(2): e13080. Disponible en: https://doi.org/10.7759/cureus.13080
21. Mahmud R, Rahman MM, Rassel MA, Monayem FB, Sayeed SKJB, Islam MS, et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLoS One [Internet]. 2021 [citado 24/02/2026]; 16(4): e0249644. Disponible en: https://doi.org/10.1371/journal.pone.0249644
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Niels Joslin Pomayay-Yaranga, Rolando Vásquez-Alva
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
